169 related articles for article (PubMed ID: 1444745)
1. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
[TBL] [Abstract][Full Text] [Related]
2. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
Sherman ME; Kelly D
Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
[TBL] [Abstract][Full Text] [Related]
3. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
Kurman RJ; Malkasian GD; Sedlis A; Solomon D
Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
[TBL] [Abstract][Full Text] [Related]
4. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
[TBL] [Abstract][Full Text] [Related]
6. The minimally abnormal Papanicolaou smear.
Brotzman GL; Julian TM
Am Fam Physician; 1996 Mar; 53(4):1154-62. PubMed ID: 8629563
[TBL] [Abstract][Full Text] [Related]
7. Colposcopic screening of women with atypical Papanicolaou smears.
Kohan S; Noumoff J; Beckman EM; Morris M; Weiner E; Douglas GW
J Reprod Med; 1985 May; 30(5):383-7. PubMed ID: 4009560
[TBL] [Abstract][Full Text] [Related]
8. Is the HSIL subclassification cytologically real and clinically justified?
Milicić-Juhas V; Pajtler M
Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108
[TBL] [Abstract][Full Text] [Related]
9. Atypical glandular cells in cervical smears: histological correlation and a suggested plan of management based on age of the patient in a low-resource setting.
Adhya AK; Mahesha V; Srinivasan R; Nijhawan R; Rajwanshi A; Suri V; Dhaliwal LK
Cytopathology; 2009 Dec; 20(6):375-9. PubMed ID: 19207306
[TBL] [Abstract][Full Text] [Related]
10. [Suspicious findings in gynecologic cytodiagnosis].
Koroschetz F
Wien Klin Wochenschr; 1991; 103(12):357-61. PubMed ID: 1926863
[TBL] [Abstract][Full Text] [Related]
11. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
12. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology.
Sherman ME; Dasgupta A; Schiffman M; Nayar R; Solomon D
Cancer; 2007 Feb; 111(1):15-25. PubMed ID: 17186503
[TBL] [Abstract][Full Text] [Related]
13. Detection of high-grade lesions on cell blocks from residual fluids of Pap smears diagnosed as low-grade abnormalities: a preliminary pilot study.
Catteau X; Simon P; Noël JC
Acta Cytol; 2012; 56(3):247-50. PubMed ID: 22555525
[TBL] [Abstract][Full Text] [Related]
14. Koilocytotic atypia and underlying dysplasia.
Shepherd J; Lynch W
J Fam Pract; 1991 Aug; 33(2):168-71. PubMed ID: 1890397
[TBL] [Abstract][Full Text] [Related]
15. Atypical reparative change on cervical/vaginal smears may be associated with dysplasia.
Rimm DL; Gmitro S; Frable WJ
Diagn Cytopathol; 1996 Jun; 14(4):374-9. PubMed ID: 8725141
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Alanen KW; Elit LM; Molinaro PA; McLachlin CM
Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
[TBL] [Abstract][Full Text] [Related]
17. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
18. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
Davey DD; Nielsen ML; Naryshkin S; Robb JA; Cohen T; Kline TS
Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory atypia on cervical smears. A diagnostic dilemma for the gynecologist.
Busseniers AE; Sidawy MK
J Reprod Med; 1991 Feb; 36(2):85-8. PubMed ID: 2010900
[TBL] [Abstract][Full Text] [Related]
20. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system.
McCluggage WG; Walsh MY; Thornton CM; Hamilton PW; Date A; Caughley LM; Bharucha H
Br J Obstet Gynaecol; 1998 Feb; 105(2):206-10. PubMed ID: 9501788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
